Mergers & Acquisitions Mergers & Acquisitions

Illumina files Grail buyout for EU review after French referral

By Natalie McNelis
  • 16 Jun 2021 17:44
  • 17 Jun 2021 04:35
Illumina filed its request for EU approval to buy cancer-testing company Grail on Wednesday, MLex has learned. 

The European Commission updated its website with the deal on Thursday, and set a deadline of July 22 to decide on the transaction.*

The US gene-sequencing company made the filing at the request of the commission, which assumed

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Natalie McNelis

Senior Correspondent

Natalie McNelis covers mergers for MLex in Brussels. Before joining MLex in 2017, she spent 20 years as an international trade and competition lawyer in law firms including Stibbe and WilmerHale. Natalie has a BA in English from Mount Holyoke College, a JD from Harvard Law School and an LLM in EU law from KU Leuven. She is admitted to the bar in New York.

Discover MLex

Stay on top of global regulatory developments

Latest News